0001178913-22-004049.txt : 20221115 0001178913-22-004049.hdr.sgml : 20221115 20221115160338 ACCESSION NUMBER: 0001178913-22-004049 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221114 FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frankel Matthew Bejosa CENTRAL INDEX KEY: 0001952634 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 221391150 MAIL ADDRESS: STREET 1: 672 PROSPECT AVE. CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813676773 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 3 1 ownership.xml X0206 3 2022-11-14 0 0001534248 Chemomab Therapeutics Ltd. CMMB 0001952634 Frankel Matthew Bejosa C/O CHEMOMAB THERAPEUTICS LTD., 672 PROSPECT AVE. PRINCETON NJ 08540 0 1 0 0 Chief Medical Officer Options to Purchase American Depositary Shares 2.07 2032-11-14 American Depositary Shares 125000 D Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. 25% of these options will vest and become exercisable on the first anniversary of November 14, 2022, and the remaining 75% of these options will vest in equal amounts over a 36-month period commencing on November 14, 2023, subject to the Reporting Person's continued service. /s/ Matthew B. Frankel 2022-11-15